SCHEMBL13148088

SCHEMBL13148088

O=Cc1ccc(C(=O)Nc2ccccc2N2CCCCC2)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 8/20 1.00
▸ ALDH1A1 P00352 5/20 0.68
▸ GAA P10253 3/20 0.68
▸ HTT P42858 3/20 0.68
▸ MAPK10 P53779 3/20 0.68
▸ L3MBTL1 Q9Y468 3/20 0.68
▸ POLB P06746 1/20 0.63
▸ MAPT P10636 3/20 0.62
▸ HPGD P15428 3/20 0.62
▸ KDM4E B2RXH2 2/20 0.62
▸ LMNA P02545 1/20 0.62
▸ ALOX15 P16050 1/20 0.60
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ ATM Q13315 3/20 0.59
▸ NPSR1 Q6W5P4 3/20 0.59
▸ NPC1 O15118 1/20 0.59
▸ TP53 P04637 1/20 0.59
▸ TSHR P16473 2/20 0.56
▸ MAPK1 P28482 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081171 0.84 CSF1R (0.75) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL13148069 0.82 CSF1R (1.00) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL13147762 0.82 CSF1R (1.00) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL13167004 0.81 ALDH1A1 (1.00) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL13147776 0.81 CSF1R (1.00) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL13147771 0.81 HPGD (0.83) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL13147773 0.79 CSF1R (0.67) CSF1RALDH1A1GAAHTTMAPK10
SCHEMBL5093277 0.79 CSF1R (1.00) CSF1RALDH1A1GAAHTTPOLB
SCHEMBL13148038 0.79 CSF1R (1.00) CSF1RALDH1A1GAAHTTPOLB
SCHEMBL13147758 0.75 CSF1R (1.00) CSF1RALDH1A1GAAHTTMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 — — US disclosed
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 — — US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
WO-2007123516-A1 C-FMS KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-11-01 — — WO disclosed
Send feedback